Smith & Howard Wealth Management’s Gilead Sciences GILD Stock Holding History

Smith & Howard Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2,420	Closed	-$283K	–	68
2015 Q2	$283K	Hold	2,420	–	–	0.12%	50
2015 Q1	$237K	Buy	+2,420	New	+$246K	0.1%	69
2014 Q4	–	Sell	-3,013	Closed	-$321K	–	55
2014 Q3	$321K	Buy	+3,013	New	+$295K	0.17%	29
2014 Q1	–	Sell	-2,035	Closed	-$153K	–	103
2013 Q4	$153K	Sell	2,035 -105	-5%	-$7.31K	0.08%	57
2013 Q3	$135K	Hold	2,140	–	–	0.08%	42
2013 Q2	$110K	Buy	+2,140	New	+$112K	0.07%	55

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Smith & Howard Wealth Management's GILD Position: Q3 2015 in Review

Smith & Howard Wealth Management sold out of Gilead Sciences (GILD) in Q3 2015, closing a stake of 2,420 shares — an estimated $283K sold.

Smith & Howard Wealth Management first reported a position in GILD in Q2 2013 and held it in 6 quarters. The position peaked at $321K in Q3 2014. 1,572 funds tracked by Wall St. Rank hold GILD as of Q3 2015.

Smith & Howard Wealth Management reported no remaining Gilead Sciences position as of Q3 2015 after selling out during the quarter.
Smith & Howard Wealth Management sold 2,420 Gilead Sciences shares in Q3 2015, an estimated $283K.
Smith & Howard Wealth Management first reported a position in Gilead Sciences in Q2 2013 and held it in 6 quarters.
Smith & Howard Wealth Management's Gilead Sciences position peaked at $321K in Q3 2014.
1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2015.

Based on Smith & Howard Wealth Management's 13F filing for Q3 2015, filed 16 Nov 2015.